DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Sotrastaurin is an investigational drug.
There have been 6 clinical trials for Sotrastaurin. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Melanoma, Uveal Neoplasms, and Lymphoma. The leading clinical trial sponsors are Novartis Pharmaceuticals, James Blachly, and Novartis.
Recent Clinical Trials for Sotrastaurin
|Trial of AEB071 in Combination With BYL719 in Patients With Melanoma||Richard D. Carvajal||Phase 1|
|A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma||Array BioPharma||Phase 1/Phase 2|
|Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients||Novartis Pharmaceuticals||Phase 2|